TARP and immunodeficiency disease: Besides, because Lck activation could initiate T cell antigen receptor signaling, and is a critical step in immune response [74], therefore LF triterpenoids probably could cause immune suppression by inhibiting Lck, and should be used very carefully on patients with immunodeficiency.